MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0009238
Forel Labs Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.05 Cr
▼ 87% YoY
Net loss · FY 2024
₹2.85 Lakh
Net margin -1.4%
EBITDA · FY 2024
-₹93,759
EBITDA margin -0.5%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹15 Cr
Issued & subscribed
Satisfied charges
₹26.5 Cr
No open charges
Company age
15 yrs
Est. 2011
Employees · EPFO
3
Provident fund records
About Forel Labs Private Limited
Data last updated:
Forel Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC074271. Its GSTIN is 36AABCF7316A1Z4 (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹15 Cr. It is led by directors Siva Rama Krishna Prasad Kodeboyina (Managing Director) and Kotte Veera Venkateswara Rao.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 37 – Ground Floor Rao & Raju Colony Road No. 2 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.05 Cr, a decline of 87% compared to the previous year. For the same year it recorded a net loss of ₹2.85 Lakh (net margin -1.4%) and EBITDA of -₹93,759 (EBITDA margin -0.5%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 24% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Forel Labs. As per MCA filings, the company has satisfied charges of ₹26.5 Cr on record. Court records list 15 cases involving the company, including 3 filed by the company and 12 filed against it; 7 cases are pending.
Forel Labs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0009238). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website forellabs.com.
Company details
CIN U24232TG2011PTC074271
Registration Number 074271
Incorporation Date 04 May 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0009238
CIN history
Forel Labs has one previous CIN (Corporate Identification Number): U24232AP2011PTC074271. The current CIN is U24232TG2011PTC074271, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2011PTC074271 | Current |
| U24232AP2011PTC074271 | Previous |
Key People
Siva Rama Krishna Prasad Kodeboyina Managing Director Kotte Veera Venkateswara Rao Director Recognitions & Rankings of Forel Labs
Contact details
Forel Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is forellabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 37 – Ground Floor Rao & Raju Colony Road No. 2 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Forel Labs Private Limited, buy the company report.
Comprehensive company report
Forel Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Forel Labs operates one associated brand: Forel Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures generic APIs for pharmaceutical use with quality assurance. | forellabs.com |
Business activity
The main business activity of Forel Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Forel Labs Private Limited, buy the company report.
Financials of Forel Labs Private Limited
FY 2025 filings availableForel Labs Private Limited reported revenue of ₹2.05 Cr (down 87% YoY) for FY 2024.
Revenue · FY 2024
₹2.05 Cr ▼ 87%
Net loss · FY 2024
₹2.85 Lakh margin -1.4%
EBITDA · FY 2024
-₹93,759 margin -0.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 87%
3 years · compounded
▼ 47%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 100%
3 years · compounded
▲ 60%
5 years · compounded
▼ 15%
Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 87% fall in the latest year. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹93,759 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Forel Labs Private Limited, buy the company report.
Board of directors of Forel Labs Private Limited
Forel Labs has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Rama Krishna Prasad Kodeboyina Also directs: Amrithani Enterprises Private Limited | Managing Director | 10 Mar 2018 | 8 Years 7 Months | Current |
| Kotte Veera Venkateswara Rao | Director | 04 May 2011 | 15 Years 5 Months | Current |
Peer comparison
Forel Labs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nine Labs Private Limited | ₹2.08 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India | |||
| Macromed Pharmaceuticals Private Limited | ₹2.07 Cr (FY 2020) | -1.0% | Puducherry, India | |||
| Forel Labs Private Limitedthis company | ₹2.05 Cr (FY 2024) | -₹2.85 Lakh | -1.4% | -87.0% | 3 | Hyderabad, Telangana, India |
| Zotoxa Pharma Private Limited | ₹2.05 Cr (FY 2024) | -72.0% | Kalol, Gujarat, India |
To see the full peer comparison of Forel Labs Private Limited, buy the company report.
Auditor
Forel Labs Private Limited is audited by Spad & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Spad & Associates | FY 2022 | 011569S |
Shareholding
The shareholding of Forel Labs Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Forel Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹26.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Sep 2012 | 10382080 | Others | ₹26.5 Cr | Satisfied |
To see the full charge records of Forel Labs Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Forel Labs Private Limited has 15 court cases on record: 3 filed by Forel Labs, 12 filed against it. 7 cases are pending and 8 are disposed.
Total cases
15
Filed by the company
3
Filed against the company
12
Pending
7
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 7 | 3 |
| High courts | 3 | 3 | 3 |
| NCLT | 3 | 2 | 1 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed against the company by M/S. Deccan Remedies Limited | Pending |
| High Court, TELANGANA | Arbitration matter | Filed against the company by M/S. Deccan Remedies Limited | Pending |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against Vannsh Life Sciences Pvt Ltd | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Deccan Remedies Ltd., and Others and 6 others | Pending |
| District court, BENGALURU RURAL, Karnataka | Criminal miscellaneous application | Filed against the company by U V Asset Reconstruction Company Ltd | Disposed |
To see the full case history of Forel Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Forel Labs Private Limited was last rated by Icra on 18 Aug 2015.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 18 Aug 2015 |
To see the full credit ratings and regulatory alerts of Forel Labs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Forel Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Forel Labs Private Limited has a workforce of 3 employees on its EPFO records as of Mar 31, 2024, across 1 active EPFO establishment.
Employee count
3
Active EPFO establishments
1
Employee growth
-94%
GST
Forel Labs has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCF7316A1Z4 | Telangana | Active | 01 Jul 2017 |
| 37AABCF7316A1Z2 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Forel Labs Private Limited, buy the company report.
Recent activity
Forel Labs Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Kodeboyina Naga Jayalakshmi ceased to be Director on 22 Feb 2021.
AGM
Forel Labs Private Limited last Annual general meeting of members was held on 31 Dec 2025 as per latest MCA records.
Filing
Forel Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 29 Sep 2012 via Charge ID 10382080 with Others was fully satisfied on 20 Feb 2023.
Ceased
Kodeboyina Naga Jayalakshmi ceased to be Director.
Ceased
Christopher Newton Benny Job Devairakkam ceased to be Additional Director.
Charges
A charge with Others of Rs. 26.50 Cr registered on 29 Sep 2012 with Charge ID 10382080 was modified on 07 Sep 2018.
Appointed
Siva Rama Krishna Prasad Kodeboyina was appointed as Managing Director.
Ceased
Siva Rama Krishna Prasad Kodeboyina ceased to be Director.
Ceased
Dileep Kumar Bayyana ceased to be Director.
Ceased
Udaya Kumar Shetty ceased to be Director.
Charges
A charge with Others amounted to Rs. 26.50 Cr with Charge ID 10382080 was registered on 29 Sep 2012.
Ceased
Jens Rainer Hesse ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Forel Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 May 2011 (15+ years old) and is registered under CIN U24232TG2011PTC074271.
Forel Labs has 2 current directors:
- Siva Rama Krishna Prasad Kodeboyina - Managing Director
- Kotte Veera Venkateswara Rao - Director
The latest financial statements of Forel Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Forel Labs is 36AABCF7316A1Z4, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCF7316A1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Forel Labs is U24232TG2011PTC074271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Forel Labs has 15 court cases on record: 3 filed by the company and 12 filed against it. 7 are pending. Most are in the district courts.
Forel Labs was incorporated on 04 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Forel Labs by revenue are Nine Labs Private Limited, Macromed Pharmaceuticals Private Limited, Zotoxa Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kodeboyina Naga Jayalakshmi ceased to be Director on 22 Feb 2021. Christopher Newton Benny Job Devairakkam ceased to be Additional Director on 31 Dec 2020. Siva Rama Krishna Prasad Kodeboyina was appointed as Managing Director on 10 Mar 2018. Forel Labs has 8 board changes on record in total.
Yes, Forel Labs is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0009238).
Forel Labs can be reached through the website forellabs.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages